EV Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2017	2016	2015	2014	2013
Cash & Equivalents	0.13	0.34	0.6	0.1	0	8.39	2.73	16.47	19.73	5.79
Cash & Cash Equivalents	0.13	0.34	0.6	0.1	0	8.39	2.73	16.47	19.73	5.79
Cash Growth	-62.16%	-44.15%	485.37%	-	-	206.69%	-83.40%	-16.53%	240.65%	-
Receivables	0.27	0.25	0.12	0	4.81	1.03	6.73	9.33	6.12	7.48
Inventory	0	0	0	0	0.4	0.13	0.36	0.36	0.42	0.31
Other Current Assets	0	0	0	0	1.29	42.51	0.83	0.68	0.48	0.67
Total Current Assets	0.39	0.59	0.72	0.1	6.5	52.05	10.66	26.84	26.75	14.26
Property, Plant & Equipment	0.04	0	6.94	6.94	6.96	5.16	7.43	41.27	34.38	11.41
Long-Term Investments	0	0	2.41	0	15.3	0	15.79	3.66	5.77	28.7
Intangible Assets	0	0	0	0	0	0	2.16	4.91	2.45	2.49
Other Long-Term Assets	-0	10.84	21.27	2.01	0.18	0	0.4	0.92	0.2	0.22
Total Long-Term Assets	0.04	10.84	30.62	8.95	24.45	6.91	25.78	50.76	42.8	42.82
Total Assets	0.43	11.42	31.34	9.05	30.95	58.95	36.44	77.6	69.56	57.08
Accounts Payable	0.1	0.21	0	0	2.23	1.66	1.71	1.73	1.82	1.52
Deferred Revenue	0	0	0	0	1.29	0	2.57	0	0.4	0.02
Current Debt	1.49	22.68	21.68	0	10.04	6.47	9.74	12.59	9.36	10.23
Other Current Liabilities	0.52	2.37	2.44	1.44	15.93	8.59	11.13	16.49	2.03	1.61
Total Current Liabilities	2.12	25.26	24.12	1.44	29.49	16.72	25.15	30.81	13.62	13.38
Long-Term Debt	0	0	0	0	0	0	0.03	0.14	0.07	0.63
Other Long-Term Liabilities	0	0	0	0	0	0	0	0	18.22	16.21
Total Long-Term Liabilities	0	0	0	0	0	0	0.03	0.14	18.29	16.84
Total Liabilities	2.12	25.26	24.12	1.44	29.49	16.72	25.18	30.95	31.91	30.22
Total Debt	1.49	22.68	21.68	0	10.04	6.47	9.77	12.73	9.43	10.86
Debt Growth	-93.41%	4.59%	-	-	55.13%	-33.76%	-23.27%	34.95%	-13.15%	-
Common Stock	0.01	0.01	0.01	0.01	0.04	8.68	0.01	0.01	0.01	0.01
Retained Earnings	-49.32	-58.47	-37.42	-37.03	-41.72	18.28	-31.98	21.21	12.68	2.69
Comprehensive Income	3.92	3.92	3.92	3.92	2.42	0	2.7	6.43	5.95	5.16
Shareholders' Equity	-1.68	-13.83	7.22	7.61	1.46	42.23	11.26	46.65	37.65	26.86
Total Liabilities and Equity	0.43	11.42	31.34	9.05	30.95	58.95	36.44	77.6	69.56	57.08
Net Cash / Debt	-1.37	-22.34	-21.08	0.1	-10.04	1.92	-7.03	3.74	10.3	-5.07
Net Cash / Debt Growth	-	-	-	-	-	-	-	-63.66%	-	-
Net Cash Per Share	-0.13	-3.09	-2.92	0.01	-1.56	0.80	-2.95	2.34	6.71	-2.64
Working Capital	-1.72	-24.67	-23.41	-1.34	-22.99	35.33	-14.49	-3.97	13.14	0.88
Book Value Per Share	-0.16	-1.91	1.00	1.05	0.23	17.52	4.72	29.16	24.53	14.00

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.